Association of IRF(4) single-nucleotide polymorphism rs12203592 with melanoma-specific survival Correspondence


Authors: Ward, S. V.; Gibbs, D. C.; Orlow, I.; Thomas, N. E.; Kanetsky, P. A.; Luo, L.; Cust, A. E.; Anton-Culver, H.; Gruber, S. B.; Gallagher, R. P.; Rosso, S.; Zanetti, R.; Dwyer, T.; Begg, C. B.; Berwick, M.; and on behalf of the GEM Study Group
Title: Association of IRF(4) single-nucleotide polymorphism rs12203592 with melanoma-specific survival
Keywords: single nucleotide polymorphism; histopathology; cancer risk; united states; follow up; cancer diagnosis; letter; melanoma; melanocyte; genotype; genetic variation; immunoregulation; immune response; blood sampling; australia; tumor growth; canada; cause specific survival; interferon regulatory factor 4; italy; cancer prognosis; breslow thickness; western australia; human; priority journal
Journal Title: British Journal of Dermatology
Volume: 183
Issue: 1
ISSN: 0007-0963
Publisher: Blackwell Publishing  
Date Published: 2020-07-01
Start Page: 163
End Page: 165
Language: English
DOI: 10.1111/bjd.18881
PUBMED: 31958143
PROVIDER: scopus
PMCID: PMC7334062
DOI/URL:
Notes: Letter -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Colin B Begg
    306 Begg
  2. Irene Orlow
    247 Orlow
  3. Sarah Vivianne Ward
    12 Ward